Bristol Myers trades higher after the FDA approves an oral medication for schizophrenia in adults, fiscal fourth-quarter ...
Roth MKM analyst William Kirk reiterated a Hold rating on Costco (COST – Research Report) today and set a price target of $755.00. The ...
Costco came in shy of revenue estimates in its fiscal fourth quarter. Costco stock looks well positioned for a potential ...
U.S. stocks traded higher this morning, with the Dow Jones index rising more than 100 points on Friday. Following the market ...
In a report released today, Michael Baker from D.A. Davidson maintained a Hold rating on Costco (COST – Research Report). The ...
Shorter-term technical measures like the stock’s 50-day and 200-day suggest that the stock’s current bullish momentum is ...
Shares jumped 6% in premarket trading after the Food and Drug Administration approved a treatment for [schizophrenia patients]( ...
Costco ( COST) is slinging a lot of gold bars as prices for the yellow metal continue to surge. Sales of gold were up "double-digits" in the most recent quarter, Costco CFO Gary Millerchip told ...